blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3337811

EP3337811 - POSITIVE ALLOSTERIC MODULATORS FOR ERYTHROPOIETIN AND ERYTHROPOIETIN RECEPTOR TO TREAT ERYTHROPOIETIN DEFICIENCY DISEASES [Right-click to bookmark this link]
Former [2018/26]NEW COMPOUNDS AS POSITIVE ALLOSTERIC MODULATORS FOR ERYTHROPOIETIN AND ERYTHROPOIETIN RECEPTOR TO TREAT ERYTHROPOIETIN DEFICIENCY DISEASES
[2020/02]
StatusNo opposition filed within time limit
Status updated on  26.03.2021
Database last updated on 08.11.2024
FormerThe patent has been granted
Status updated on  17.04.2020
FormerGrant of patent is intended
Status updated on  07.01.2020
FormerRequest for examination was made
Status updated on  25.05.2018
FormerThe international publication has been made
Status updated on  27.01.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Wu, Rong-Tsun
5F., No.65
Aly.3, Ln.219, Sec.7
Zhongshan N. Road
Beitou District
Taipei City 112 / TW
[2020/21]
Former [2018/26]For all designated states
Wu, Rong-Tsun
5F., No.65
Aly.3, Ln.219, Sec.7
Zhongshan N. Road
Beitou District
Taipei City 112 / TW
Inventor(s)01 / HORNG, Lin-Yea
4F., No.59
Ln.105
Tianmu E.Rd.
Shilin Dist.
Taipei City Taiwan 111 / TW
02 / WU, Rong-Tsun
5F., No.65
Aly.3, Ln.219, Sec.7
Zhongshan N. Raod
Beitou District
Taipei City 112/TW / TW
 [2020/18]
Former [2018/26]01 / HORNG, Lin-Yea
4F., No.59
Ln.105
Tianmu E.Rd.
Shilin Dist.
Taipei City Taiwan 111 / TW
Representative(s)Straus, Alexander, et al
2K Patent- und Rechtsanwälte
Bajuwarenring 14
82041 Oberhaching / DE
[N/P]
Former [2020/21]Straus, Alexander, et al
2K Patent- und Rechtsanwälte Dr. Alexander Straus
Keltenring 9
82041 München / Oberhaching / DE
Former [2018/26]Becker Kurig Straus
Patentanwälte
Bavariastrasse 7
80336 München / DE
Application number, filing date16826986.825.07.2016
[2018/26]
WO2016CN00413
Priority number, dateUS201562195916P23.07.2015         Original published format: US 201562195916 P
[2018/26]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017012289
Date:26.01.2017
Language:EN
[2017/04]
Type: A1 Application with search report 
No.:EP3337811
Date:27.06.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 26.01.2017 takes the place of the publication of the European patent application.
[2018/26]
Type: B1 Patent specification 
No.:EP3337811
Date:20.05.2020
Language:EN
[2020/21]
Search report(s)International search report - published on:CN26.01.2017
(Supplementary) European search report - dispatched on:EP11.02.2019
ClassificationIPC:C07H15/203, C07H15/20, A61K31/7034, A61P7/06
[2020/02]
CPC:
C07H15/203 (EP,KR,US); C07H15/20 (EP,KR,US); A61P11/00 (EP);
A61P13/12 (EP); A61P25/20 (EP); A61P25/28 (EP);
A61P27/02 (EP); A61P27/04 (EP); A61P35/00 (EP);
A61P7/06 (EP,KR); A61P9/04 (EP) (-)
Former IPC [2018/26]C07H15/203, A61K31/7034, A61P7/06
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/26]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:POSITIVE ALLOSTERISCHE MODULATOREN FÜR ERYTHROPOIETIN UND ERYTHROPOIETINREZEPTOR ZUR BEHANDLUNG VON ERYTHROPOIETINMANGELERKRANKUNGEN[2020/02]
English:POSITIVE ALLOSTERIC MODULATORS FOR ERYTHROPOIETIN AND ERYTHROPOIETIN RECEPTOR TO TREAT ERYTHROPOIETIN DEFICIENCY DISEASES[2020/02]
French:MODULATEURS ALLOSTÉRIQUES POSITIFS POUR L'ÉRYTHROPOÏÉTINE ET LE RÉCEPTEUR DE L'ÉRYTHROPOÏÉTINE POUR LE TRAITEMENT DE MALADIES LIÉES À UNE DÉFICIENCE EN ÉRYTHROPOÏÉTINE[2020/02]
Former [2018/26]NEUE VERBINDUNGEN ALS POSITIVE ALLOSTERISCHE MODULATOREN FÜR ERYTHROPOIETIN UND ERYTHROPOIETINREZEPTOR ZUR BEHANDLUNG VON ERYTHROPOIETINMANGELERKRANKUNGEN
Former [2018/26]NEW COMPOUNDS AS POSITIVE ALLOSTERIC MODULATORS FOR ERYTHROPOIETIN AND ERYTHROPOIETIN RECEPTOR TO TREAT ERYTHROPOIETIN DEFICIENCY DISEASES
Former [2018/26]NOUVEAUX COMPOSÉS UTILISÉS EN TANT QUE MODULATEURS ALLOSTÉRIQUES POSITIFS POUR L'ÉRYTHROPOÏÉTINE ET LE RÉCEPTEUR DE L'ÉRYTHROPOÏÉTINE POUR LE TRAITEMENT DE MALADIES LIÉES À UNE DÉFICIENCE EN ÉRYTHROPOÏÉTINE
Entry into regional phase02.01.2018National basic fee paid 
02.01.2018Search fee paid 
02.01.2018Designation fee(s) paid 
02.01.2018Examination fee paid 
Examination procedure02.01.2018Examination requested  [2018/26]
02.01.2018Date on which the examining division has become responsible
05.09.2019Amendment by applicant (claims and/or description)
08.01.2020Communication of intention to grant the patent
09.04.2020Fee for grant paid
09.04.2020Fee for publishing/printing paid
09.04.2020Receipt of the translation of the claim(s)
Opposition(s)23.02.2021No opposition filed within time limit [2021/17]
Fees paidRenewal fee
11.07.2018Renewal fee patent year 03
29.05.2019Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU25.07.2016
AL20.05.2020
AT20.05.2020
CY20.05.2020
CZ20.05.2020
DK20.05.2020
EE20.05.2020
ES20.05.2020
FI20.05.2020
HR20.05.2020
IT20.05.2020
LT20.05.2020
LV20.05.2020
MC20.05.2020
MK20.05.2020
MT20.05.2020
NL20.05.2020
PL20.05.2020
RO20.05.2020
RS20.05.2020
SE20.05.2020
SI20.05.2020
SK20.05.2020
SM20.05.2020
TR20.05.2020
IE25.07.2020
LU25.07.2020
BE31.07.2020
BG20.08.2020
NO20.08.2020
GR21.08.2020
IS20.09.2020
PT21.09.2020
[2022/32]
Former [2022/27]HU25.07.2016
AL20.05.2020
AT20.05.2020
CY20.05.2020
CZ20.05.2020
DK20.05.2020
EE20.05.2020
ES20.05.2020
FI20.05.2020
HR20.05.2020
IT20.05.2020
LT20.05.2020
LV20.05.2020
MC20.05.2020
MT20.05.2020
NL20.05.2020
PL20.05.2020
RO20.05.2020
RS20.05.2020
SE20.05.2020
SI20.05.2020
SK20.05.2020
SM20.05.2020
TR20.05.2020
IE25.07.2020
LU25.07.2020
BE31.07.2020
BG20.08.2020
NO20.08.2020
GR21.08.2020
IS20.09.2020
PT21.09.2020
Former [2021/37]AL20.05.2020
AT20.05.2020
CZ20.05.2020
DK20.05.2020
EE20.05.2020
ES20.05.2020
FI20.05.2020
HR20.05.2020
IT20.05.2020
LT20.05.2020
LV20.05.2020
MC20.05.2020
NL20.05.2020
PL20.05.2020
RO20.05.2020
RS20.05.2020
SE20.05.2020
SI20.05.2020
SK20.05.2020
SM20.05.2020
IE25.07.2020
LU25.07.2020
BE31.07.2020
BG20.08.2020
NO20.08.2020
GR21.08.2020
IS20.09.2020
PT21.09.2020
Former [2021/24]AL20.05.2020
AT20.05.2020
CZ20.05.2020
DK20.05.2020
EE20.05.2020
ES20.05.2020
FI20.05.2020
HR20.05.2020
IT20.05.2020
LT20.05.2020
LV20.05.2020
MC20.05.2020
NL20.05.2020
PL20.05.2020
RO20.05.2020
RS20.05.2020
SE20.05.2020
SI20.05.2020
SK20.05.2020
SM20.05.2020
LU25.07.2020
BE31.07.2020
BG20.08.2020
NO20.08.2020
GR21.08.2020
IS20.09.2020
PT21.09.2020
Former [2021/20]AL20.05.2020
AT20.05.2020
CZ20.05.2020
DK20.05.2020
EE20.05.2020
ES20.05.2020
FI20.05.2020
HR20.05.2020
IT20.05.2020
LT20.05.2020
LV20.05.2020
MC20.05.2020
NL20.05.2020
PL20.05.2020
RO20.05.2020
RS20.05.2020
SE20.05.2020
SK20.05.2020
SM20.05.2020
LU25.07.2020
BG20.08.2020
NO20.08.2020
GR21.08.2020
IS20.09.2020
PT21.09.2020
Former [2021/13]AL20.05.2020
AT20.05.2020
CZ20.05.2020
DK20.05.2020
EE20.05.2020
ES20.05.2020
FI20.05.2020
HR20.05.2020
IT20.05.2020
LT20.05.2020
LV20.05.2020
MC20.05.2020
NL20.05.2020
PL20.05.2020
RO20.05.2020
RS20.05.2020
SE20.05.2020
SK20.05.2020
SM20.05.2020
BG20.08.2020
NO20.08.2020
GR21.08.2020
IS20.09.2020
PT21.09.2020
Former [2021/10]AL20.05.2020
AT20.05.2020
CZ20.05.2020
DK20.05.2020
EE20.05.2020
ES20.05.2020
FI20.05.2020
HR20.05.2020
IT20.05.2020
LT20.05.2020
LV20.05.2020
NL20.05.2020
PL20.05.2020
RO20.05.2020
RS20.05.2020
SE20.05.2020
SK20.05.2020
SM20.05.2020
BG20.08.2020
NO20.08.2020
GR21.08.2020
IS20.09.2020
PT21.09.2020
Former [2021/09]AL20.05.2020
AT20.05.2020
CZ20.05.2020
DK20.05.2020
EE20.05.2020
ES20.05.2020
FI20.05.2020
HR20.05.2020
IT20.05.2020
LT20.05.2020
LV20.05.2020
NL20.05.2020
RO20.05.2020
RS20.05.2020
SE20.05.2020
SM20.05.2020
BG20.08.2020
NO20.08.2020
GR21.08.2020
IS20.09.2020
PT21.09.2020
Former [2021/08]AL20.05.2020
DK20.05.2020
ES20.05.2020
FI20.05.2020
HR20.05.2020
LT20.05.2020
LV20.05.2020
NL20.05.2020
RO20.05.2020
RS20.05.2020
SE20.05.2020
SM20.05.2020
BG20.08.2020
NO20.08.2020
GR21.08.2020
IS20.09.2020
PT21.09.2020
Former [2021/04]AL20.05.2020
FI20.05.2020
HR20.05.2020
LT20.05.2020
LV20.05.2020
NL20.05.2020
RS20.05.2020
SE20.05.2020
BG20.08.2020
NO20.08.2020
GR21.08.2020
IS20.09.2020
PT21.09.2020
Former [2021/01]FI20.05.2020
HR20.05.2020
LT20.05.2020
LV20.05.2020
RS20.05.2020
SE20.05.2020
BG20.08.2020
NO20.08.2020
GR21.08.2020
IS20.09.2020
PT21.09.2020
Former [2020/51]FI20.05.2020
HR20.05.2020
LT20.05.2020
LV20.05.2020
RS20.05.2020
SE20.05.2020
NO20.08.2020
GR21.08.2020
IS20.09.2020
PT21.09.2020
Former [2020/50]FI20.05.2020
HR20.05.2020
LT20.05.2020
LV20.05.2020
SE20.05.2020
NO20.08.2020
GR21.08.2020
IS20.09.2020
PT21.09.2020
Former [2020/48]FI20.05.2020
LT20.05.2020
SE20.05.2020
NO20.08.2020
IS20.09.2020
PT21.09.2020
Former [2020/47]LT20.05.2020
NO20.08.2020
IS20.09.2020
Former [2020/46]IS20.09.2020
Documents cited:Search   [ ] - No further relevant documents disclosed
International search[A]CN101161245  (XUANWU HOSPITAL OF CAPITAL UNI [CN]) [A] 1-15 * claims 1 and 8 *;
 [X]WO2010075263  (WU SOPHIA SHU FEN [US], et al) [X] 1-15 * claims 1-17, examples 1-8 *;
 [A]CN103156868  (TIANJIN INT JOINT ACADEMY BIOTECHNOLOGY & MEDICINE) [A] 1-15 * description, paragraphs [0009]-[0014] *;
 [X]WO2014158165  (WU SOPHIA SHU FEN [US], et al) [X] 1-15 * claims 1-40, examples 1-4 *;
 [A]CN104586865  (KUNMING PHARMACEUTICAL GROUP) [A] 1-15 * description, paragraphs [0006]-[0021] *;
 [PX]  - CARDULLO, NUNZIO et al., "Resveratrol-Related Polymethoxystilbene Glycosides: Synthesis, Antiproliferative Activity, and Glycosidase Inhibition", JOURNAL OF NATURAL PRODUCTS, (20151105), vol. 78, pages 2675 - 2683, XP055347592 [PX] 1, 3, 5, 7-10 * , compound 20 *

DOI:   http://dx.doi.org/10.1021/acs.jnatprod.5b00619
by applicantWO2010075263
 WO2014158165
    - MAY, L.T. et al., Annual review of pharmacology and toxicology, (20070000), vol. 47, pages 1 - 51
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.